|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales, net | |||||
| Product | |||||
| Product and Service, Other | |||||
| Total sales, net | |||||
| Cost of goods sold | |||||
| Total cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Goodwill, intangible and other asset impairment | |||||
| Loss on divestiture of subsidiary | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Non-cash (loss) gain on changes in fair value of warrant liability | |||||
| Extinguishment of Secured Convertible Note | |||||
| Non-cash (loss) gain on changes in fair value of embedded derivative liability | |||||
| Non-cash gain on changes in fair value of contingent liability | |||||
| Accretion of interest and amortization of discounts on convertible notes | |||||
| Non-cash loss on modification of common stock warrants | |||||
| Other expense, net | |||||
| Provision for income taxes | |||||
| Net loss from continuing operations | |||||
| Net income from held-for-sale assets (Note 22) | |||||
| Net income from discontinued operations, net of taxes | |||||
| Net loss | |||||
| Less: Increase to accumulated deficit due to adjustment to common stock warrant exercise price | |||||
| Less: Increase to accumulated deficit due to adjustment to Preferred Stock conversion price | |||||
| Net loss attributable to common stockholders | |||||
| Weighted average shares outstanding: | |||||
| Basic (and diluted for net loss) (in shares) | |||||
| Basic and diluted net loss per share | |||||
| Basic loss per share from continuing operations (in dollars per share) | |||||
| Basic earnings per share from discontinued operations (in dollars per share) | |||||
| Basic (loss) earnings per share attributable to common stockholders (in dollars per share) | |||||
Loading...